ClinicalTrials.gg

Program

NCR100

A development code. Also written as “NCR100 injection”.

Its studies are mostly in Osteoarthritis, Knee, led by Nuwacell Biotechnologies.

Furthest: phase 2, since Dec 16, 20243 company-led studies, 3 open or runningNext primary completion: Nov 30, 2026 (phase 2)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Nuwacell Biotechnologies33 open or runningphase 2since Dec 16, 2024Sep 6, 2023Nov 30, 2026phase 2 · NCT06741098

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Sep 6, 2023First study: phase 1 study in Osteoarthritis, KneeFirst studyNCT06049342 · 12 planned
  2. Dec 16, 2024Phase 2 study in Osteoarthritis, KneeNCT06741098 · 162 planned
  3. Aug 17, 2025Phase 1 study in KOANCT07139431 · 6 planned

Ahead

  1. Nov 30, 2026Primary completion: phase 2 study in Osteoarthritis, KneeNCT06741098

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 3 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07139431KOA1Not yet recruitingMar 6, 20266
NCT06741098Osteoarthritis, Knee2Not yet recruitingNov 30, 2026162
NCT06049342Osteoarthritis, Knee1Not yet recruitingJun 202412

How it is read

Names in the registry

  • “NCR100”, 2 entries
  • “NCR100 injection”, 1 entry

Codes read as this program: NCR100.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.